Get Latest Update About Chronic Lymphocytic Leukemia on Webcast. This webcast will discuss Chronic Lymphocytic Leukemia. This presentation will first discuss the approach and diagnosis to lymphocytosis. It will use case presentations to highlight the presentation and evaluation of chronic lymphocytic leukemia (CLL). The presenter will also review complications and health maintenance implications for CLL. The second half of the talk will discuss staging and risk stratification. The presenter will review the rationale for observation and indications for treatment as well as the various different treatment options and their associated side effects.
Patients with CLL can have nonspecific symptoms like fatigue and lymphadenopathy—or be entirely asymptomatic. As a result, many cases of CLL are first detected incidentally through routine bloodwork showing lymphocytosis. Unlike many cancers, CLL often progresses so slowly that some patients may not need treatment. Others may not be so lucky and suffer devastating complications such as cytopenias, infections, and secondary malignancies. On this webcast, we’ve invited two Ohio State University’s Hematology experts who both specialize in CLL to discuss this common subtype of Leukemia. How do we diagnose it? And how do we manage it? We’re pleased to introduce Assistant Professor of Hematology Dr. Aseel Alsouqi. Aseel treats not only patients with CLL but also non-Hodgkin’s lymphoma and is an investigator on several clinical trials for leukemia and lymphoma. We also have Associate Professor of Hematology Dr. Seema Bhat. In addition to her clinical treating of patients with CLL, Seema is also a principal investigator on clinical trials for novel CLL therapies.
What you’ll learn in this webcast
As a result of this educational activity, webcast participants will be able to:
- Learn the basic diagnostic work up for CLL
- Understand the health implications of CLL
- Understanding Staging and Risk Stratification of CLL
- Understand rationale of observation for early-stage asymptomatic patients with CLL and approach to select treatment for CLL when indicated.
You’ll also learn about the following:
- Prognosis
- Evolution of CLL
- PCP’s role
- Therapies
- CLL Patients in the Hospital
You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Webcast Producer at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.